Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Platinum II Complexes")

Filter

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 11701

  • Page / 469
Export

Selection :

  • and

Liposomes as vehicles for water insoluble platinum-based potential drug: 2-(4-(Tetrahydro-2H-pyran-2-yloxy)-undecyl)-propane-1,3-diamminedichloroplatinum(II)KATUDEROVIC, Goran N; DIETRICH, Andrea; KOMMERA, Harish et al.European journal of medicinal chemistry. 2012, Vol 54, pp 567-572, issn 0223-5234, 6 p.Article

Circadian time-dependent tissue uptake of cisplatin (CDDP) and carboplatin (CBDCA) following repeated administrations : relationship with drug toxicities in miceBOUGHATTAS, N. A; FOURNIER, C; HECQUET, B et al.Annual review of chronopharmacology. 1990, Vol 7, pp 231-234, issn 0743-9539, 4 p.Conference Paper

Composés du Pt(II) à visée antitumorale, dérivés de l'ellipticine et de ses analogues = Antitumoral compounds of Pt(II), derivatives of ellipticine and its analoguesBENAZETH, S; BAZIN, D; VIOSSAT, B et al.Journal de chimie physique. 1989, Vol 86, Num 7-8, pp 1635-1642, issn 0021-7689, 8 p.Article

Adduct formation of cis-(NH3)2PtX2 (X=Cl-,I-) with formamides and the crystal structures of cis-(NH3)2PtCl2•(CH3)2NCHO. Application for the purification of the antitumor agent cisplatinRAUDASCHL, G; LIPPERT, B; HOESCHELE, J. D et al.Inorganica chimica acta. 1985, Vol 106, Num 3, pp 141-149, issn 0020-1693Article

Cis-dichlorodiammineplatinum(II) has a binding specificity for adjoining guanine basesINAGAKI, K; KIDANI, Y.Inorganica chimica acta. 1985, Vol 106, Num 4, pp 187-191, issn 0020-1693Article

Cyclopentadienyldifluorphosphin und Homologe als Liganden in cis-Dichloroplatin(II)-Komplexen ― Struktur von cis-(C5Me5PF2)2PtCl2 und cis-(C9H7PF2)[(C9H7)3P]PtCl2 (C5Me5=Pentamethylcyclopentadienyl, C9H7-Indenyl) = Cyclopentadienyldifluorophosphine and its homologues as ligands in eis-dichloroplatinum(II) complexes. Structure of cis-(C5Me5PF2)2PtCl2 and cis-(C9H7PF2)[(C9H7)3P]PtCl2 (C5Me5=pentamethylcyclopentadienyl, C9H7=indenyl)HEUER, L; BODE, U. K; JONES, P. G et al.Zeitschrift für Naturforschung. B, A journal of chemical sciences. 1989, Vol 44, Num 9, pp 1082-1092, issn 0932-0776, 11 p.Article

Paraplatin (carboplatin) current status and future prospects: proceedings/3rd European conference on clinical oncologyCARTER, S. K; HELLMANN, K.Cancer treatment reviews. 1985, Vol 12, issn 0305-7372, 152 p., suppl. AConference Proceedings

High-dose cisplatin in hypertonic salineOZOLS, R. F; CORDEN, B. J; JACOB, J et al.Annals of internal medicine. 1984, Vol 100, Num 1, pp 19-24, issn 0003-4819Article

Immunostimulatory effect of cis-diamine dichloroplatinum(II)RIHOVA, B; DROBNIK, J; RIHA, I et al.Immunology letters. 1984, Vol 8, Num 2, pp 57-60, issn 0165-2478Article

Dual electrode liquid chromatography-electrochemical detection (LCEC) for platinum-derived cancer chemotherapy agentsDING, H.-D; KRULL, I. S.Journal of liquid chromatography. 1983, Vol 6, Num 12, pp 2173-2194, issn 0148-3919Article

In vitro binding of platinum compounds to human transferrinSYKES, T. R; STEPHENS-NEWSHAM, L. G; NOUJAIM, A. A et al.Research communications in chemical pathology and pharmacology. 1985, Vol 50, Num 3, pp 387-394, issn 0034-5164Article

The radiomimetic properties of a platinum drugBAROT, H. A; LAVERICK, M; NIAS, A. H. W et al.British journal of radiology. 1985, Vol 58, Num 685, pp 51-62, issn 0007-1285Article

Synthesis and in vitro antiproliferative activity of platinum(II) complexes with N-monoalkyl 1R,2R-diaminocyclohexane as ligandsYANYAN SUN; FEI LIU; SHAOHUA GOU et al.European journal of medicinal chemistry. 2012, Vol 55, pp 297-306, issn 0223-5234, 10 p.Article

Design, synthesis and in vitro cytotoxicity of a cis-dichloroplatinum (II) complex linked to the minor groove binder stallimycinBARALDI, Pier Giovanni; MOJGAN AGHAZADEH TABRIZI; PAVANI, Maria Giovanna et al.Arzneimittel-Forschung. 2003, Vol 53, Num 2, pp 107-113, issn 0004-4172, 7 p.Article

EFFECT OF CISPLATIN ON THE PLASMA MEMBRANE PHOSPHATASE ACTIVITIES IN ASCITES SARCOMA-180 CELLS: A CYTOCHEMICAL STUDYAGGARWAL SK; NIROOMAND RAD I.1983; JOURNAL OF HISTOCHEMISTRY AND CYTOCHEMISTRY; ISSN 0022-1554; USA; DA. 1983; VOL. 31; NO 2; PP. 307-317; BIBL. 60 REF.Article

HPLC SEPARATION AND COMPARATIVE TOXICITY OF SAXITOXIN AND ITS REACTION PRODUCTSRUBINSON KA.1982; BIOCHIMICA ET BIOPHYSICA ACTA; ISSN 0006-3002; NLD; DA. 1982; VOL. 687; NO 2; PP. 314-320; BIBL. 18 REF.Article

TOXICITY OF CISPLATIN AND HYDROXYMALONATODIAMMINE PLATINUM (II) TOWARDS MOUSE BONE MARROW AND B16 MELANOMA IN RELATION TO DNA BINDING IN VIVOPERA MF JR; SESSFORD D; ROBERTS JJ et al.1982; BIOCHEM. PHARMACOL.; ISSN 0006-2952; GBR; DA. 1982; VOL. 31; NO 13; PP. 2273-2278; BIBL. 16 REF.Article

Synthesis of bis(phosphine)-1,2-dihydroplatina(II)cyclobutabenzenes. Molecular structure of the 1,2-dihydroplatina(II) cyclobutabenzene Pt(CH2-o-C6H4)(PMe3)2DE BOER, H. J. R; SCHAT, G; AKKERMAN, O. S et al.Organometallics. 1989, Vol 8, Num 5, pp 1288-1291, issn 0276-7333, 4 p.Article

In vitro mechanisms study of microtubule assembly inhibition by cis-dichlorodiammine-platinum(II)PEYROT, V; BRIAND, C; MOMBURG, R et al.Biochemical pharmacology. 1986, Vol 35, Num 3, pp 371-375, issn 0006-2952Article

Binding behavior of antitumor R,R-1,2-cyclohexanediamine platinum(II) with oligonucleotides and DNAINAGAKI, K; KASUYA, K; KIDANI, Y et al.Chemistry Letters. 1984, Num 2, pp 171-174, issn 0366-7022Article

In the search for new anticancer drugs. VII: Platinum complexes of diaziridines and azetidineSOSNOVSKY, G; LUKSZO, J.Journal of cancer research and clinical oncology. 1984, Vol 107, Num 3, pp 217-220, issn 0171-5216Article

Site-specifically platinated DNA, a new probe of the biological activity of platinum anticancer drugsPINTO, A. L; NASER, L. J; ESSIGMANN, J. M et al.Journal of the American Chemical Society. 1986, Vol 108, Num 23, pp 7405-7407, issn 0002-7863Article

Polarographic activity of the antitumor drug cis-dichlorodiammineplatinum (II). The effect of hydrolysis and trans-isomerization of the drugVRANA, O; KLEINWÄCHTER, V; BRABEC, V et al.Experientia. 1984, Vol 40, Num 5, pp 446-451, issn 0014-4754Article

Cis-diamminedichloroplatinum(II) nephrotoxicity and its relationship to renal γ-glutamyl transpeptidase and glutathione = Néphrotoxicité du cis-platine et sa relation avec le gammaglutamyltranspeptidase et le glutathion rénauxLEYLAND-JONES, B; MORROW, C; TATE, S et al.Cancer research (Baltimore). 1983, Vol 43, Num 12, pp 6072-6076, issn 0008-5472Article

FIABILITE DE LA PONCTION CYTOLOGIQUE: QUI DOIT PONCTIONNER LES TUMEURS DU SEIN. = RELIABILITY OF NEEDLE CYTOLOGY: WHO SHOULD PERFORM ASPIRATION BIOPSY OF THE BREAST.DE RANIERI E; MANDARD AM; JURET P et al.1983; PRESSE (LA) MEDICALE (1983); ISSN 512281; FRA; DA. 1983; VOL. 12; NO 24; PP. 1527-1529; ABS. ENG/FRE; BIBL. 9 REF.Article

  • Page / 469